Moreover, in this study, the CR-1 interference treatment + paclitaxel/cisplatin combination therapy further reduced the SPF while further increasing the apoptotic activity of ESCC cells, suggesting a synergistic effect between CR-1 interference and these two drugs in promoting G2/M phase arrest and apoptosis. Here, CR1 is linked to esophageal squamous cell carcinoma.